Human Milk Oligosaccharides (HMO) Market Set to Grow at 24.6% CAGR Through 2031 - QYResearch

Los Angeles, United States - QY Research has released a new publication titled "Global Human Milk Oligosaccharides (HMO) Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031." This comprehensive study provides an in-depth evaluation of the worldwide Human Milk Oligosaccharides (HMO) industry, uncovering the major forces influencing market growth and delivering high-value insights for investors, industry leaders, and strategic decision-makers. The report examines critical elements such as market dynamics, evolving technologies, segmentation trends, regional developments, and the competitive landscape. With data backed by rigorous research and expert interpretation, it offers an authoritative guide to understanding the macroeconomic and microeconomic factors reshaping the global market.

The global market for Human Milk Oligosaccharides (HMO) was estimated to be worth US$ 708 million in 2024 and is forecast to a readjusted size of US$ 3225 million by 2031 with a CAGR of 24.6% during the forecast period 2025-2031.

Download FREE Sample PDF (Including Full TOC, Tables & Charts): https://qyresearch.in/request-sample/food-beverages-human-milk-oligosaccharides-hmo-global-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Human Milk Oligosaccharides (HMO) are a class of complex carbohydrates naturally found in human breast milk. They are composed of multiple sugar units linked by glycosidic bonds. HMOs are one of the most abundant components in human milk after fat, protein, and lactose, and their concentration is significantly higher in human milk compared to other mammals. HMOs play a crucial role in infant health, serving as prebiotics that promote the growth of beneficial bacteria, such as bifidobacteria, helping to establish a healthy gut microbiome and enhance immune system function.

HMOs vary in structure, including monosaccharides, disaccharides, trisaccharides, and longer polysaccharide chains. Different types of HMOs have distinct biological functions, helping to combat pathogen invasion, reduce inflammation, and support brain development. While HMOs are primarily found in human milk, advances in technology have made it possible to extract and synthesize these oligosaccharides through fermentation and chemical processes for use in commercial products like infant formula, functional foods, and health supplements.

With ongoing research into the benefits of HMOs in infant health and other wellness applications, the demand for human milk oligosaccharides has been steadily increasing, particularly in infant formula and adult prebiotic foods.

Market Development Opportunities and Key Drivers: -

As consumer awareness of health increases, especially in regard to infant health, the market for human milk oligosaccharides (HMOs) is experiencing significant growth opportunities. In recent years, extensive research on the role of HMOs in infant health has led more infant formula manufacturers to incorporate HMOs into their products to support immune function and gut health. Additionally, HMOs have shown potential in adult health applications, particularly in maintaining gut microbiome balance and enhancing immune function, opening new growth avenues for the market. As the global population ages and the demand for functional foods rises, there is also growing demand for prebiotic products targeting adults.

Market Risks: -

Despite the promising outlook for the HMO market, there are several risks. First, the production of HMOs is complex and costly, which may hinder product accessibility and price competitiveness. Second, the HMO supply chain is intricate, involving multiple stages such as raw material extraction and fermentation. Any technological challenges or disruptions in production could affect the stability of the entire supply chain. Moreover, global regulatory and standard differences may pose challenges to market expansion, particularly in terms of varying regulatory policies and certification requirements in different countries.

Market Concentration: -

Currently, the HMO production market is relatively concentrated, with several leading biotech and pharmaceutical companies dominating the industry. These companies have advanced fermentation and biosynthesis technologies that enable large-scale production while maintaining high quality. However, as technology advances and the market expands, more small and medium-sized enterprises are expected to enter the market, fostering competition and innovation.

Downstream Demand Trends: -

The downstream demand for HMOs is mainly concentrated in infant formula, prebiotic foods and supplements, and personalized nutrition products. As consumers increasingly demand personalized and functional nutrition products, the market for HMOs as a functional ingredient will continue to grow. Additionally, the potential for HMOs in aging populations is being recognized, particularly for supporting gut health and immune systems in elderly individuals.

Latest Technologies: -

The production technology for HMOs is continually evolving, with innovations in fermentation and biosynthesis reducing production costs. Furthermore, the application of genetic engineering and synthetic biology has opened up possibilities for customized HMO production, allowing for optimized efficiency and yields through genetically modified microorganisms.

Major Company Included: -

Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem

The competitive section of the report provides essential insights needed for companies to strengthen their market positioning. It highlights the strategies adopted by leading players-covering innovation, pricing models, marketing channels, distribution networks, and regional expansion. This evaluation enables market participants to identify competitive advantages and understand challenges that may affect their long-term performance.

Market Segmentation -

The report presents a granular breakdown of the global Human Milk Oligosaccharides (HMO) market, emphasizing CAGR, market share, future potential, and emerging trends across each segment.

By Type

2'-FL & 3-FL
LNT & LNnT, etc.

By Application

Infant Formula
Others

This segmentation helps identify high-growth niches and valuable investment opportunities across product types and applications.

Regional Analysis -

The report offers a detailed geographic assessment covering four major regions and key contributing countries. Insights include consumption patterns, production levels, market share distribution, and long-term growth prospects.

North America

United States

Canada

Mexico

Latin America

Brazil

Other key regional markets

Asia-Pacific

China

Japan

India

South Korea

ASEAN Countries

Europe, Middle East & Africa (EMEA)

Germany

France

United Kingdom

GCC Countries

African Nations

The analysis spans from 2024 (base year) to 2031 (forecast period).

Pre-Order / Enquiry Link: https://qyresearch.in/pre-order-inquiry/food-beverages-human-milk-oligosaccharides-hmo-global-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Why This Report Is Essential -

✔ Complete Historical & Forecast Analysis (2020-2031)
✔ Detailed Segmentation by Type, Application & Region
✔ In-Depth Competitive Landscape & Company Profiling
✔ Drivers, Restraints & Market Dynamics Explained
✔ Expert Insights to Support Strategic Planning

Report Objectives -

Measure the global Human Milk Oligosaccharides (HMO) market size (value & volume).

Accurately analyze market shares, consumption trends, and segment performance.

Examine major market dynamics and industry-shaping forces.

Identify and discuss key production, revenue, and sales trends.

Profile top market players and evaluate their competitive strategies.

Review manufacturing practices, pricing structures, and cost trends.

Compare regional and national market performance across key geographies.

Forecast segment-wise and region-wise growth opportunities through 2031.

Key Questions Answered in the Report -

What is the size and estimated growth rate of the global and regional Human Milk Oligosaccharides (HMO) market?

Which countries are expected to display the strongest growth?

Which region will dominate the market throughout the forecast period?

What are the main factors driving or restraining market expansion?

What technological advancements are shaping future demand?

Where are the key opportunities for new entrants and established players?

Which companies currently hold the highest market share?

How will market dynamics evolve from 2025 to 2031?

Table of Contents - Major Key Points:

1 Market Overview
1.1 Human Milk Oligosaccharides (HMO) Product Introduction
1.2 Global Human Milk Oligosaccharides (HMO) Market Size Forecast (2020-2031)
1.3 Human Milk Oligosaccharides (HMO) Market Trends & Drivers
1.3.1 Human Milk Oligosaccharides (HMO) Industry Trends
1.3.2 Human Milk Oligosaccharides (HMO) Market Drivers & Opportunity
1.3.3 Human Milk Oligosaccharides (HMO) Market Challenges
1.3.4 Human Milk Oligosaccharides (HMO) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Milk Oligosaccharides (HMO) Players Revenue Ranking (2024)
2.2 Global Human Milk Oligosaccharides (HMO) Revenue by Company (2020-2025)
2.3 Key Companies Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Human Milk Oligosaccharides (HMO) Product Offered
2.5 Key Companies Time to Begin Mass Production of Human Milk Oligosaccharides (HMO)
2.6 Human Milk Oligosaccharides (HMO) Market Competitive Analysis
2.6.1 Human Milk Oligosaccharides (HMO) Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Human Milk Oligosaccharides (HMO) Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Milk Oligosaccharides (HMO) as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 2'-FL & 3-FL
3.1.2 LNT & LNnT, etc.
3.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Type
3.2.1 Global Human Milk Oligosaccharides (HMO) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Human Milk Oligosaccharides (HMO) Sales Value, by Type (2020-2031)
3.2.3 Global Human Milk Oligosaccharides (HMO) Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Infant Formula
4.1.2 Others
4.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Application
4.2.1 Global Human Milk Oligosaccharides (HMO) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Human Milk Oligosaccharides (HMO) Sales Value, by Application (2020-2031)
4.2.3 Global Human Milk Oligosaccharides (HMO) Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Human Milk Oligosaccharides (HMO) Sales Value by Region
5.1.1 Global Human Milk Oligosaccharides (HMO) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Region (2020-2025)
5.1.3 Global Human Milk Oligosaccharides (HMO) Sales Value by Region (2026-2031)
5.1.4 Global Human Milk Oligosaccharides (HMO) Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031
5.2.2 North America Human Milk Oligosaccharides (HMO) Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031
5.3.2 Europe Human Milk Oligosaccharides (HMO) Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031
5.4.2 Asia Pacific Human Milk Oligosaccharides (HMO) Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031
5.5.2 South America Human Milk Oligosaccharides (HMO) Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031
5.6.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Milk Oligosaccharides (HMO) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031
6.3 United States
6.3.1 United States Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031
6.3.2 United States Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031
6.4.2 Europe Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031
6.5.2 China Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031
6.6.2 Japan Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031
6.7.2 South Korea Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031
6.8.2 Southeast Asia Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Human Milk Oligosaccharides (HMO) Sales Value, 2020-2031
6.9.2 India Human Milk Oligosaccharides (HMO) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Human Milk Oligosaccharides (HMO) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Profile
7.1.2 Abbott Main Business
7.1.3 Abbott Human Milk Oligosaccharides (HMO) Products, Services and Solutions
7.1.4 Abbott Human Milk Oligosaccharides (HMO) Revenue (US$ Million) & (2020-2025)
7.1.5 Abbott Recent Developments
7.2 Inbiose
7.2.1 Inbiose Profile
7.2.2 Inbiose Main Business
7.2.3 Inbiose Human Milk Oligosaccharides (HMO) Products, Services and Solutions
7.2.4 Inbiose Human Milk Oligosaccharides (HMO) Revenue (US$ Million) & (2020-2025)
7.2.5 Inbiose Recent Developments
7.3 Glycom
7.3.1 Glycom Profile
7.3.2 Glycom Main Business
7.3.3 Glycom Human Milk Oligosaccharides (HMO) Products, Services and Solutions
7.3.4 Glycom Human Milk Oligosaccharides (HMO) Revenue (US$ Million) & (2020-2025)
7.3.5 Glycom Recent Developments
7.4 Chr. Hansen (Jennewein)
7.4.1 Chr. Hansen (Jennewein) Profile
7.4.2 Chr. Hansen (Jennewein) Main Business
7.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Products, Services and Solutions
7.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Revenue (US$ Million) & (2020-2025)
7.4.5 Chr. Hansen (Jennewein) Recent Developments
7.5 Elicityl SA
7.5.1 Elicityl SA Profile
7.5.2 Elicityl SA Main Business
7.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Products, Services and Solutions
7.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Revenue (US$ Million) & (2020-2025)
7.5.5 Elicityl SA Recent Developments
7.6 ZuChem
7.6.1 ZuChem Profile
7.6.2 ZuChem Main Business
7.6.3 ZuChem Human Milk Oligosaccharides (HMO) Products, Services and Solutions
7.6.4 ZuChem Human Milk Oligosaccharides (HMO) Revenue (US$ Million) & (2020-2025)
7.6.5 ZuChem Recent Developments
8 Industry Chain Analysis
8.1 Human Milk Oligosaccharides (HMO) Industrial Chain
8.2 Human Milk Oligosaccharides (HMO) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Milk Oligosaccharides (HMO) Sales Model
8.5.2 Sales Channel
8.5.3 Human Milk Oligosaccharides (HMO) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

About Us:

QYResearch established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

Contact Us:

Arshad Shaha | Marketing Executive

QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - arshad@qyrindia.com
Web - https://www.qyresearch.in

This release was published on openPR.